A new study provides new clues for the links between aging and neurodegenerative diseases.
A new method reveals some ALS affected neurons display hypo-excitability. Researchers say these changes most likely represent early steps in the disease progression.
Researchers shed light on how stress granules, enzymes linked to a range of neurodegenerative diseases, are formed and how they can be reduced.
Tongue range motion is reduced while lower lip and jaw motion is increased in people who suffer dysarthria associated with ALS. The findings may help develop new therapies to help those with ALS improve their speech, researchers say.
A new collaborative study has helped researchers to uncover some of the earliest molecular events in ALS.
Researchers reveal a small region of Ataxin-2, a protein implicated in long term memory, may drive the progression of ALS.
A new immunotherapy treatment for ALS patients is not only safe, but can also help slow the progression of the disease, researchers report.
Researchers report transplanting altered neural stem cells into the brains of mice genetically engineered to exhibit symptoms of ALS, delayed the progression of the disease and extended lifespan.
Researchers report the formation of larger, more visible SOD1 aggregates may help to protect brain cells.
Researchers have discovered a method to engraft immune cells in the brains of lab mice without the use of radiation.
Gene expressions in the brain that occur early in development may explain why some cerebellar stem cell populations behave differently in people with SCA1, researchers report.
A new study reveals many inhibitory neurons are lost in early phases of ALS and FTD development. The findings show a contrast to other neurodegenerative diseases where excitatory neurons are lost early in the disorders.
